Open tender · Germany · Cn Standard
Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit der Wirkstoffkombination aus Lamivudin, Tenofovirdisoproxil und Doravirin (ATC-Code: J05AR24).
The work
Conclusion of a non-exclusive discount contract for a specific drug combination within a specified period.
- Contract must be for the drug combination Lamivudin, Tenofovirdisoproxil and Doravirin (ATC-Code: J05AR24).
- Contract duration is a maximum of 24 months.
- Earliest contract start date is 01.03.2026.
- All contracts end no later than 29.02.2028.
Key facts
- Contract period
- Maximum 24 months
What it takes to qualify
Worth a closer look
- The tender is not a public procurement in the sense of Directive 2014/24/EU.
- The publication is for transparency and does not imply submission under procurement law.
- The exact input deadlines are to be specified in the contract documents.
Experience
- At least 1 similar work — Experience with pharmaceutical discount contracts for the specified drug combination (ATC-Code: J05AR24).
Certifications and registrations
Pharmazeutischer Unternehmer i. S. d. § 4 Abs. 18 AMG§ 130a Abs. 8 Satz 1 SGB V requires contracts only with pharmaceutical entrepreneurs as defined by § 4 Abs. 18 AMG.
Policy conditions
No reservation, preference or local-content restriction.
Documents to submit
- VertragsunterlagenContract documents must be submitted to AOK Niedersachsen.